Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Afrezza® INHALE-1 Study in Pediatrics

ClinicalTrials.gov ID: NCT04974528

Public ClinicalTrials.gov record NCT04974528. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 16, 2026, 7:21 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

INHALE-1: A 26-week Primary Treatment Phase, With 26-week Extension, Open-label, Randomized Clinical Trial Evaluating the Efficacy and Safety of Afrezza® Versus Rapid-acting Insulin Analog Injections, Both in Combination With a Basal Insulin, in Pediatric Subjects With Type 1 or Type 2 Diabetes Mellitus

Study identification

NCT ID
NCT04974528
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Mannkind Corporation
Industry
Enrollment
319 participants

Conditions and interventions

Interventions

  • Afrezza Biological
  • Basal Insulin Biological
  • Rapid-acting Insulin Analog Biological

Biological

Eligibility (public fields only)

Age range
4 Years to 17 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 28, 2021
Primary completion
Oct 2, 2024
Completion
Apr 28, 2025
Last update posted
May 5, 2025

2021 – 2025

United States locations

U.S. sites
39
U.S. states
25
U.S. cities
38
Facility City State ZIP Site status
Children's Hospital Los Angeles Los Angeles California 90027
Children's Hospital of Orange County Orange California 92868
Stanford University Palo Alto California 94304
Sutter Institute for Medical Research (formerly Center of Excellence in Diabetes and Endocrinology) Sacramento California 95821
University of California San Diego, Rady Children's Hospital San Diego California 92123
University of California San Francisco San Francisco California 94158
Yale New Haven Hospital New Haven Connecticut 06511
Nemours Children's Hospital, Delaware Wilmington Delaware 19803
University of Florida Gainesville Florida 32610
Joe DiMaggio Children's Hospital Hollywood Florida 33021
Advent Health Orlando Orlando Florida 32803
University of South Florida Tampa Florida 33612
Emory University, Children's Healthcare of Atlanta Atlanta Georgia 30329
Rocky Mountain Clinical Research Idaho Falls Idaho 83404
Indiana University Indianapolis Indiana 46202
University of Iowa Iowa City Iowa 52242
Iowa Diabetes Research, IDR West Des Moines Iowa 50265
University of Louisville, Norton Children's Hospital Louisville Kentucky 40202
Dr. Barry J. Reiner Baltimore Maryland 21229
Johns Hopkins University Baltimore Maryland 21287
Joslin Diabetes Center Boston Massachusetts 02215
Michigan Pediatric Endocrine and Diabetes Services Livonia Michigan 48152
University of Minnesota Minneapolis Minnesota 55455
Children's Mercy Hospital Kansas City Missouri 64111
The DOCS Las Vegas Nevada 89113
Atlantic Health Morristown New Jersey 07960
UBMD Pediatrics Buffalo Buffalo New York 14203
NYU Langone, Hassenfeld Children's Hospital New York New York 10016
Cincinnati Children's Hospital Cincinnati Ohio 45229
University Hospitals Cleveland Medical Center Cleveland Ohio 44106
Oklahoma Children's Hospital Oklahoma City Oklahoma 73104
Children's Hospital of Philadelphia Philadelphia Pennsylvania 19104
AM Diabetes and Endocrinology Center Bartlett Tennessee 38133
UT Southwestern Dallas Texas 75390
DHR Health Edinburg Texas 78539
Diabetes & Glandular Disease Clinic, DGD San Antonio Texas 78229
Virginia Commonwealth University Richmond Virginia 23298
Seattle Children's Seattle Washington 98105
Medical College of Wisconsin Milwaukee Wisconsin 53201

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04974528, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 5, 2025 · Synced May 16, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04974528 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →